Fever-range whole body hyperthermia prevents the onset of type 1 diabetes in non-obese diabetic mice

References

• Yoon J-W, Jun H-S. Autoimmune destruction of pancreatic beta cells. Am J Therapeutics 2005; 12: 580–591
   PubMedGoogle Scholar
• Aly T, Devendra D, Eisenbarth GS. Immunotherapeutic approaches to prevent, ameliorate, and cure type I diabetes. Am J Therapeutics 2005; 12: 481–490
   PubMedGoogle Scholar
• Makino S, Kunimoto K, Muraoka Y, Mizushima Y, Katagiri K, Kikutani H. Breeding of a non-obese, diabetic strain of mice. Jikken Dobutsu 1980; 29: 1–13
   PubMedGoogle Scholar
• Kikutani H, Makino S. The murine autoimmune diabetes model: NOD and related strains. Adv Immunol 1992; 51: 285–322
   PubMed Web of Science ®Google Scholar
• Anderson MS, Bluestone JA. The NOD mouse: A model of immune dysregulation. AnnRev Immunol 2005; 23: 447–485
   Google Scholar
• Sadelain MWJ, Qin H-Y, Lauzon J, Singh B. Prevention of Type I diabetes in NOD mice by adjuvant immunotherapy. Diabetes 1990; 39: 1–6
   PubMed Web of Science ®Google Scholar
• Ulaeto D, Lacy PE, Kipnis DM, Kanagawa O, Unanue ER. A T cell dormant state in the autoimmune process of nonobese diabetic mic treated with complete Freund's adjuvant. PNAS 1992; 89: 3927–3931
   PubMed Web of Science ®Google Scholar
• Qin H-Y, Sadelain MWJ, Hitchon C, Lauzon J, Singh B. Complete Freund's adjuvant-induced T cells prevent the development and adoptive transfer of diabetes in nonobese diabetic mice. J Immunol 1993; 150: 2072–2080
   PubMed Web of Science ®Google Scholar
• Lee I-F, Qin H, Trudeau J, Dutz J, Tan R. Regulation of autoimmune diabetes by complete Freund's adjuvant is mediated by NK cells. J Immunol 2004; 172: 937–942
   PubMed Web of Science ®Google Scholar
• Ogasawara K, Hamerman JA, Hsin H, Chikuma S, Bour-Jordan H, Chen T, Pertel T, Bluestone JA, Carnaud C, Lanier LL. Impairment of NK cell function by NKG2D modulation in NOD mice. Immunity 2003; 18: 41–51
   PubMed Web of Science ®Google Scholar
• Ostberg JR, Gellin C, Patel R, Repasky EA. Regulatory potential of fever-range whole body hyperthermia on Langerhans cells and lymphocytes in an antigen-dependent cellular immune response. J Immunol 2001; 167: 2666–2670
   PubMed Web of Science ®Google Scholar
• Ostberg JR, Repasky EA. Emerging evidence indicates that physiologically relevant thermal stress regulates dendritic cell function. Cancer. Immunol Immunother 2006; 55: 292–298
   PubMed Web of Science ®Google Scholar
• Ostberg JR, Patel R, Repasky EA. Regulation of immune activity by mild (fever-range) whole body hyperthermia: Effects on epidermal Langerhans cells. Cell Stress Chaperones 2000; 5: 458–461
   PubMed Web of Science ®Google Scholar
• Ostberg JR, Kabingu E, Repasky EA. Thermal regulation of dendritic cell activation and migration from skin explants. Int J Hyperthermia 2003; 19: 520–533
   PubMed Web of Science ®Google Scholar
• Pritchard MT, Li A, Repasky E. Nitric oxide production is regulated by fever-range thermal stimulation of murine macrophages. J Leukocyte Biol 2005; 78: 630–638
   PubMed Web of Science ®Google Scholar
• Ostberg JR, Dayanc BE, Yuan M, Oflazoglu E, Repasky EA. Enhancement of natural killer (NK) cell cytotoxicity by fever-range thermal stress is dependent upon NKG2D function and is associated with plasma membrane NKG2D clustering and increased expression of MICA on target cells. J Leukocyte Biol 2007; 82: 1322–1331
   PubMed Web of Science ®Google Scholar
• Burd R, Dziedzic TS, Xu Y, Caligiuri MA, Subjeck JR, Repasky EA. Tumor cell apoptosis, lymphocyte recruitment and tumor vascular changes are induced by low temperature, long duration (fever-like) whole body hyperthermia. J Cell Physiol 1998; 177: 137–147
   PubMed Web of Science ®Google Scholar
• Pritchard MT, Ostberg JR, Evans SS, Burd R, Kraybill W, Bull JM, Repasky EA. Protocols for simulating the thermal component of fever: Preclinical and clinical experience. Methods 2004; 32: 54–62
   PubMed Web of Science ®Google Scholar
• Shen RN, Hornbeck NB, Shidnia H, Wu B, Lu L, Broxmeyer HE. Whole body hyperthermia: A potent radioprotector in vivo. Int J Radiat Oncol, Biol, Phys 1991; 20: 525–530
   PubMed Web of Science ®Google Scholar
• Thurnher M, Ramoner R, Gastl G, Radmayr C, Bock G, Herold M, Klocker H, Bartsch G. Bacillus Calmette-Guerin mycobacteria stimulate human blood dendritic cells. Int J Cancer 1997; 70: 128–134
   PubMed Web of Science ®Google Scholar
• Carnaud C, Lee D, Donnars O, Park SH, Beavis A, Koezuka Y, Bendelac A. Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J Immunol 1999; 163: 4647–4650
   PubMed Web of Science ®Google Scholar
• Zitvogel L. Dendritic and natural killer cells cooperate in the control/switch of innate immunity. J Exp Med 2002; 195: F9–F14
   PubMed Web of Science ®Google Scholar
• Slifka MK, Pagarigan RR, Whitton JL. NK markers are expressed on a high percentage of virus-specific CD8+ and CD4+ T cells. J Immunol 2000; 164: 2009–2015
   PubMed Web of Science ®Google Scholar
• Xu Y, Choi J, Hylander B, Sen A, Evans S, Kraybill W, Repasky EA. Fever-range whole body hyperthermia increases the number of perfused tumor blood vessels and therapeutic efficacy of liposomally encapsulated doxorubicin. Int J Hyperthermia 2007; 23: 513–527
   PubMed Web of Science ®Google Scholar
• Kraybill W, Olenki T, Evans S, Ostberg J, O'Leary K, Gibbs F, Repasky EA. A phase I study of fever-range whole body hyperthermia (FR-WBH) in patients with advanced solid tumors: Correlation with mouse models. Int J Hyperthermia 2002; 18: 253–266
   PubMed Web of Science ®Google Scholar
• Rowe-Horwege RW. Hyperthermia, systemic encyclopedia of medical devices and intrumentation. John Wiley and Sons, Inc, New York 2006
   Google Scholar